NCT05073276

Non- vs Partial Controlled Weightbearing After Multiple Knee Ligament Reconstruction

Non-Weight Bearing Versus Partial Controlled Weightbearing During the First Six Weeks of Rehabilitation After Multiple Knee Ligament Reconstruction: A Randomized Controlled Trial
Twin Cities Orthopedics·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Knee Injuries
Drug/Device/Intervention
Physical Therapy
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Twin Cities Orthopedics
Location
Edina, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2020
End date
Jan 01, 2026
Enrollment
50 participants
Primary outcome

Gapping (mm) measured on Standard of Care Varus stress radiographs,Gapping (mm) measured on Standard of Care Varus stress radiographs

Summary

This is a prospective randomized controlled trial with the purpose to determine if patients
 undergoing isolated posterior cruciate ligament (PCL) reconstruction, or isolated medial
 collateral ligament (MCL) reconstruction, or combined PCL, anterior cruciate ligament (ACL),
 fibular collateral ligament (FCL), posterolateral corner (PLC), and MCL reconstructions (or
 any combination of multiple ligaments) can safely begin partial controlled weightbearing for
 the first six weeks after surgery.

ICD-10 classifications
Injuries to the knee and lower legSprain and strain of other and unspecified parts of kneeOther spontaneous disruption of ligament(s) of kneeCrushing injury of kneeInjury to multiple structures of knee
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05073276
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05073276 through Pure Global AI's free database. This phase not specified trial is sponsored by Twin Cities Orthopedics and is currently Recruiting. The study focuses on Knee Injuries. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.